Abstract
Tubercle bacilli separated from young cultures were thoroughly extracted with monochlorobenzene at temperatures never exceeding 50°C. From the soluble material, a fraction corresponding to approximately 1 per cent of the total bacillary weight was separated by fractional precipitation with petrolic ether at temperatures of 0° or 4°C.—depending upon the strain of bacilli. The monochlorobenzene-soluble-ether-insoluble material (fraction 7) prepared from BCG-P was found to contain 0.14 per cent nitrogen and 0.4 per cent phosphorus. Some of its other chemical characteristics are described. Fraction 7 proved unable to elicit tuberculin allergy in guinea pigs, but injection of 5 µg. of it into the skin produced severe local reactions. In albino mice, a single intraperitoneal injection of 20 µg. caused loss of muscular tone and of weight followed by death within 9 days. The only tissue reaction observed was a slight degree of peritonitis. In mice of the C57 BL strain, a single injection of 40 µg. also caused death in the same time, but with pulmonary hemorrhages—usually massive. Material similar to fraction 7 was obtained from one virulent, two attenuated, and one avirulent strain of mammalian tubercle bacilli (bovine and human). The fractions obtained from the various strains differed somewhat in solubility and toxicity. The more virulent the culture, the more toxic was the fraction obtained from it; but it is possible that this relation was the result of differences in the effectiveness of the extraction procedures, rather than of characteristics inherent to the cultures. Evidence is presented that the toxicity of fraction 7 accounts for much of the primary toxicity of tubercle bacilli.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ASSELINEAU J., BLOCH H., LEDERER E. A toxic lipid component of the tubercle bacillus (cord factor). III. Occurrence and distribution in various bacterial extracts. Am Rev Tuberc. 1953 Jun;67(6):853–858. doi: 10.1164/art.1953.67.6.853. [DOI] [PubMed] [Google Scholar]
- BLOCH H. Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J Exp Med. 1950 Feb;91(2):197-218, pl. doi: 10.1084/jem.91.2.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choucroun N. BIOLOGICAL EFFECTS OF A TOXIC AND A SENSITIZING SUBSTANCE ISOLATED FROM PARAFFIN OIL EXTRACT OF DEAD TUBERCLE BACILLI. Science. 1943 Oct 8;98(2545):327–329. doi: 10.1126/science.98.2545.327. [DOI] [PubMed] [Google Scholar]
- DUBOS R. J., MIDDLEBROOK G. Cytochemical reaction of virulent tubercle bacilli. Am Rev Tuberc. 1948 Dec;58(6):698–698. doi: 10.1164/art.1948.58.6.698. [DOI] [PubMed] [Google Scholar]
- DUBOS R. J., SCHAEFER W. B., PIERCE C. H. Antituberculous immunity in mice vaccinated with killed tubercle bacilli. J Exp Med. 1953 Feb 1;97(2):221–233. doi: 10.1084/jem.97.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PIERCE C. H., DUBOS R. J., SCHAEFER W. B. Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med. 1953 Feb 1;97(2):189–206. doi: 10.1084/jem.97.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RAFFEL S. Chemical factors involved in the induction of infectious allergy. Experientia. 1950 Nov 15;6(11):410–419. doi: 10.1007/BF02150118. [DOI] [PubMed] [Google Scholar]
- Sabin F. R., Doan C. A. THE BIOLOGICAL REACTIONS IN RABBITS TO THE PROTEIN AND PHOSPHATIDE FRACTIONS FROM THE CHEMICAL ANALYSIS OF HUMAN TUBERCLE BACILLI. J Exp Med. 1927 Sep 30;46(4):645–669. doi: 10.1084/jem.46.4.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEISS D. W., DUBOS R. J. Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract. J Exp Med. 1955 Mar 1;101(3):313–330. doi: 10.1084/jem.101.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YOUMANS G. P., YOUMANS A. S. The assessment of antituberculous chemotherapeutic activity in mice, using virulent human-type tubercle bacilli. Am Rev Tuberc. 1951 Nov;64(5):541–550. doi: 10.1164/art.1951.64.5.541. [DOI] [PubMed] [Google Scholar]